The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Michael Dickinson Scientific Advisory Board Member

Michael Dickinson Scientific Advisory Board Member

Doctor Michael Dickinson is a clinical hematologist at the  Peter MacCallum Cancer Centre, Melbourne, AU, and is the Lead of the Aggressive Lymphoma Stream within the Integrated Haematology Service. Dr Dickinson obtained his medical degree at the  University of Western Australia, Perth, AU, and trained as a physician in Brisbane, AU, and London, UK. He is a Julie Borschmann Fellow of Myeloma Research,  University of Melbourne, Melbourne, AU.

Dr Dickinson’s research areas of interest include aggressive lymphoma, myelodysplastic syndromes, acute myeloid leukemia, and myeloma. He is a Principal Investigator in phase I/II studies, mainly in aggressive lymphoma. His research focuses on the role of epigenetic modifiers and immunotherapies in hematological malignancies and the use of eltrombopag as a supportive care agent in myeloid malignancies. Additionally, he researches novel methods of molecular analysis for patients with lymphoid malignancies.

Positions of responsibility/awards:

| |